Pharmaceutical Supply Chain Initiative

Overview

Industry initiative with 85 member pharma companies (~70% of global pharma turnover, ~$1.2T aggregate) building responsible supply chains through common audit frameworks, decarbonization, and human rights programs. The Pharmaceutical Supply Chain Initiative has 85 member companies representing approximately 70% of global pharmaceutical turnover, or about $1.2 trillion US dollars in aggregate. The PSCI began as a joint audit program approximately 10 years before the 2026 panel and now covers decarbonization, human rights, and environmental topics, offering common audit frameworks and supplier support on a mission of building responsible supply chains. (PSCI Scale (Segment 5, 20:00-25:00))